Eurocine Vaccines AB (publ) reported earnings results for the fourth quarter ended June 30, 2022. For the fourth quarter, the company reported revenue was SEK 0.043 million compared to SEK 0.002 million a year ago. Net loss was SEK 5.19 million compared to SEK 6.06 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0354 SEK | -6.84% | -11.50% | -23.04% |
1st Jan change | Capi. | |
---|---|---|
-23.04% | 878K | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- EUCI Stock
- News Eurocine Vaccines AB
- Eurocine Vaccines AB Reports Earnings Results for the Fourth Quarter Ended June 30, 2022